BeOne Medicines (ONC) Property, Plant & Equipment (Net) Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.71% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -0.31% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 21.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.04% |
| Dec 31, 2025 | 92.64% |
| Sep 30, 2025 | 33.65% |
| Jun 30, 2025 | 36.66% |
| Mar 31, 2025 | 36.78% |
| Dec 31, 2024 | 39.01% |
| Sep 30, 2024 | 51.35% |
| Jun 30, 2024 | 56.56% |
| Mar 31, 2024 | 55.94% |
| Dec 31, 2023 | 54.70% |
| Sep 30, 2023 | 59.34% |
| Jun 30, 2023 | 58.72% |
| Mar 31, 2023 | 56.74% |
| Dec 31, 2022 | -1.79% |
| Sep 30, 2022 | 44.40% |
| Jun 30, 2022 | 43.85% |
| Mar 31, 2022 | 46.71% |
| Dec 31, 2021 | 55.24% |
| Sep 30, 2021 | 59.42% |
| Jun 30, 2021 | 63.44% |
| Mar 31, 2021 | 69.35% |
| Dec 31, 2020 | 78.81% |
| Sep 30, 2020 | 73.96% |
| Jun 30, 2020 | 96.98% |
| Mar 31, 2020 | 98.51% |
| Dec 31, 2019 | 110.53% |
| Sep 30, 2019 | 139.18% |
| Jun 30, 2019 | 179.39% |
| Mar 31, 2019 | 195.04% |
| Dec 31, 2018 | 187.46% |